Výsledky vyhledávání

Selective corticosteroid and calcineurin-inhibitor withdrawal after pancreas-kidney transplantation utilizing thymoglobulin induction and sirolimus maintenance therapy

Autor: R J, Knight, R H, Kerman, E, McKissick, A, Lawless, H, Podder, S, Katz, C T, Van Buren, B D, Kahan

Publikováno v: Clinical transplantation. 22(5)

Of 25 simultaneous pancreas-kidney transplant (SPK) recipients treated with thymoglobulin induction, sirolimus and reduced-dose cyclosporine (CsA), 18 low-immune responders (non-African-Americans, PRA30%) were withdrawn from prednisone on post-transp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::4607e9ff9299f382043ca99df576ecc8
https://pubmed.ncbi.nlm.nih.gov/18657156

Zobrazit plný text záznamu

DRB1*1613N: a novel DRB1 allele with a premature termination codon

Autor: W, Zhao, E, Guerrero, R H, Kerman, P, Cano, M A, Fernández-Viña

Publikováno v: Tissue antigens. 71(2)

DRB1 null alleles are extremely rare and always sporadic, suggesting their biological selective disadvantage.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::99c02f1a0d60c37fe6d8d9744aee9974
https://pubmed.ncbi.nlm.nih.gov/18086264

Zobrazit plný text záznamu

Flow cytometry-detected IgG is not a contraindication to renal transplantation: IgM may be beneficial to outcome

Autor: R H, Kerman, B, Susskind, I, Buyse, P, Pryzbylowski, J, Ruth, S, Warnell, S A, Gruber, S, Katz, C T, Van Buren, B D, Kahan

Publikováno v: Transplantation. 68(12)

At our transplant center, primary recipients of either a haplo-identical (haplo-ID) living related (LRD) or a cadaveric (CAD) donor renal allograft are transplanted after a negative donor-specific IgG anti-human globulin (AHG) cross-match (XM). Testi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f12394760c79a1533d09d78012fb1c2f
https://pubmed.ncbi.nlm.nih.gov/10628764

Zobrazit plný text záznamu

Comparison between enzyme-linked immunosorbent assay and cytotoxic cross-match procedures for detecting IgG anti-donor antibodies

Autor: B, Susskind, R H, Kerman, R, Nelson, J, Gregory, T, La, A, Bayat, M, Dang, C, Van Buren, S, Katz, B D, Kahan

Publikováno v: Transplantation. 66(12)

Disadvantages inherent to complement-dependent cytotoxicity cross-match (CDC XM) methods are the requirements for complement and viable target cells, detection of antibodies (Abs) against non-HLA antigens, and subjective scoring. Cross-Stat (SangStat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::8ee808151e944fc27bf581f619689de9
https://pubmed.ncbi.nlm.nih.gov/9884282

Zobrazit plný text záznamu

Can an immunologically, nonreactive potential allograft recipient undergo transplantation without a donor-specific crossmatch?

Autor: R H, Kerman, B, Susskind, J, Ruth, S, Katz, C T, Van Buren, B D, Kahan

Publikováno v: Transplantation. 66(12)

Performance of the pretransplant crossmatch requires 4 or more hours . Delays in the crossmatch might alter operating room availability and thereby increase donor organ cold ischemia time that might then result in increased risk of delayed graft func

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::45059a195b8529f244b53743da2e6afe
https://pubmed.ncbi.nlm.nih.gov/10706066

Zobrazit plný text záznamu

Comparison of PRA-STAT, sHLA-EIA, and anti-human globulin-panel reactive antibody to identify alloreactivity in pretransplantation sera of heart transplant recipients: correlation to rejection and posttransplantation coronary artery disease

Autor: R H, Kerman, B, Susskind, D, Kerman, M, Lam, K, Gerolami, J, Williams, R, Kalish, M, Campbell, S, Katz, C T, Van Buren, H, Frazier, B, Radovancevic, S, Fife, B, Kahan

Publikováno v: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 17(8)

Screening pretransplantation recipient sera for percent panel reactive antibodies (%PRA) by an anti-human globulin (AHG) assay may identify recipients who are at risk for graft rejection or development of posttransplantation coronary artery disease.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c025a27701eeb0c334f477a04326abe4
https://pubmed.ncbi.nlm.nih.gov/9730428

Zobrazit plný text záznamu

Correlation of ELISA-detected IgG and IgA anti-HLA antibodies in pretransplant sera with renal allograft rejection

Autor: R H, Kerman, B, Susskind, R, Buelow, J, Regan, P, Pouletty, J, Williams, K, Gerolami, D H, Kerman, S M, Katz, C T, Van Buren, B D, Kahan

Publikováno v: Transplantation. 62(2)

The present study compared the occurrence of rejection episodes during the first twelve posttransplant (Tx) months and the 1-, 2-, and 3-year graft survivals among recipients stratified by the percent panel reactive antibody (% PRA) of pre-Tx sera as

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b0b0ea2df933bc1db4833ade3f1e3fcb
https://pubmed.ncbi.nlm.nih.gov/8755816

Zobrazit plný text záznamu

The impact of elevated serum IgA and race on primary recipient renal allograft survival

Autor: B M, Susskind, R H, Kerman, B J, Browne, B A, Hartwell, B G, Davis, S M, Katz, C T, Van Buren, B D, Kahan

Publikováno v: Transplantation. 61(2)

This study correlated overall serum IgA levels in pretransplant (preTx) sera with graft survival. IgA levels, determined by nephelometry, were normally distributed, with a mean level of 255 +/- 139 mg/dl and a median of 234 mg/dl in 631 adult primary

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::00b7008e93531574a6ea7f4985ff6789
https://pubmed.ncbi.nlm.nih.gov/8600624

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání